Drug major Sun Pharma will acquire GlaxoSmithKline's Opiates business in Australia for an undisclosed amount to strengthen its pain management portfolio. Both companies said they expect to close the deal by August. #Australia#Sun Pharma#Pharma#gsk#Tasmania#opiates
China has fined GlaxoSmithKline Plc a record 3 billion yuan ($488.8 million) for paying bribes to doctors to use its drugs, the British company said on Friday, drawing to a close a corruption probe that rocked the pharmaceutical sector in China. #China#Corruption#Bribery#gsk#GlaxoSmithKline Plc
The initiative represents a bid by Britain's biggest drugmaker to get ahead of its critics by addressing potential conflicts of interest that could put commercial interests ahead of the best outcome for patients.